Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Eukaryotic Gene Expression
Facteur d'impact: 1.734 Facteur d'impact sur 5 ans: 1.848 SJR: 0.627 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimer: 1045-4403
ISSN En ligne: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v22.i4.10
pages 269-279

Intraoperative Radiation Therapy

Harold James Wallace III
Division of Radiation Oncology, University of Vermont College of Medicine, Burlington, Vermont
James H. Goodwin
Division of Radiation Oncology, University of Vermont College of Medicine, Burlington, Vermont

RÉSUMÉ

Radiation therapy has been used to treat cancers for over one hundred years. Over the last century our understanding of the biology of radiation exposure as well as our ability to safely deliver extraordinarily high doses of radiation to specific targets has led to its routine use in both curative and palliative settings for most solid tumors. External radiation beam techniques invariably involve irradiating normal tissues that are located between the radiation source and the intended target. High-energy linear accelerators have greatly reduced skin and subcutaneous radiation-induced injury; however, radiation tolerances of organs adjacent to the target do frequently limit the total amount of radiation that can be used. Intraoperative radiation therapy (IORT) can be delivered in a number of ways, with the ultimate intent of minimizing normal tissue exposure to potentially harmful doses of radiation. Multiple IORT delivery modalities are now available, all of which present potential advantages and disadvantages over other methods of treatment. The specific techniques, radiobiologic considerations, and clinical uses of IORT will be described.


Articles with similar content:

Exploiting the Tumor Phenotype Using Biodegradable Submicron Carriers of Chemotherapeutic Drugs
Critical Reviews™ in Oncogenesis, Vol.19, 2014, issue 3-4
Aliasger K. Salem, Sean M. Geary
Nanostructured Delivery Systems: Augmenting the Delivery of Antiretroviral Drugs for Better Management of HIV/AIDS
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.32, 2015, issue 6
Sanaul Mustafa, Roopa S Pai, Gurinder Singh
Emerging Role of Vesicular Carriers for Therapy of Visceral Leishmaniasis: Conventional versus Novel
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.27, 2010, issue 6
Navneet Kumar, Suresh P. Vyas, Anuradha Dube, Swati Gupta
Therapeutic Opportunities in Colon-Specific Drug-Delivery Systems
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.24, 2007, issue 2
Avani Amin, Mayur M. Patel, Tejal Shah
Current Perspectives on Novel Drug Carrier Systems and Therapies for Management of Pancreatic Cancer: An Updated Inclusive Review
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.35, 2018, issue 3
Rohit R. Bhosale, Bannimath Gurupadayya, Devegowda Vishakante Gowda, Koganti Venkata Sairam, Riyaz Ali Mahafez Ali Osmani, Rudra Vaghela, Hosahalli Veerabhadrappa Gangadharappa, Parthasarathi Keshavarao Kulkarni